Human Immunodeficiency Virus Type 1 Vpr Induces G₂ Checkpoint Activation by Interacting with the Splicing Factor SAP145

REFERENCES

• Bennett, M., S. Pinol-Roma, D. Staknis, G. Dreyfuss, and R. Reed. 1992. Differential binding of heterogeneous nuclear ribonucleoproteins to mRNA precursors prior to spliceosome assembly in vitro. Mol. Cell. Biol. 12:3165–3175.
   PubMedGoogle Scholar
• Ben-Yehuda, S., I. Dix, C. S. Russell, M. McGarvey, J. D. Beggs, and M. Kupiec. 2000. Genetic and physical interactions between factors involved in both cell cycle progression and pre-mRNA splicing in Saccharomyces cerevisiae. Genetics 156:1503–1517.
   PubMedGoogle Scholar
• Berglez, J. M., L. A. Castelli, S. A. Sankovich, S. C. Smith, C. C. Curtain, and I. G. Macreadie. 1999. Residues within the HFRIGC sequence of HIV-1 vpr involved in growth arrest activities. Biochem. Biophys. Res. Commun. 264:287–290.
   PubMedGoogle Scholar
• Brosi, R., H. P. Hauri, and A. Kramer. 1993. Separation of splicing factor SF3 into two components and purification of SF3a activity. J. Biol. Chem. 268:17640–17746.
   PubMed Web of Science ®Google Scholar
• Bryant, H. E., S. E. Wadd, A. I. Lamond, S. J. Silverstein, and J. B. Clements. 2001. Herpes simplex virus IE63 (ICP27) protein interacts with spliceosome-associated protein 145 and inhibits splicing prior to the first catalytic step. J. Virol. 75:4376–4385.
   PubMedGoogle Scholar
• Burma, S., B. P. Chen, M. Murphy, A. Kurimasa, and D. J. Chen. 2001. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276:42462–42467.
   PubMed Web of Science ®Google Scholar
• Champion-Arnaud, P., and R. Reed. 1994. The prespliceosome components SAP 49 and SAP 145 interact in a complex implicated in tethering U2 snRNP to the branch site. Genes Dev. 15:1974–1983.
   Google Scholar
• Coeytaux, E., D. Coulaud, E. Le Cam, O. Danos, and A. Kichler. 2003. The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J. Biol. Chem. 278:18110–18116.
   PubMedGoogle Scholar
• Das, B. K., L. Xia, L. Palandjian, O. Gozani, Y. Chyung, and R. Reed. 1999. Characterization of a protein complex containing spliceosomal proteins SAPs 49, 130, 145, and 155. Mol. Cell. Biol. 19:6796–6802.
   PubMed Web of Science ®Google Scholar
• Emerman, M., and M. H. Malim. 1998. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280:1880–1884.
   PubMed Web of Science ®Google Scholar
• Fernandez-Capetillo, O., A. Lee, M. Nussenzweig, and A. Nussenzweig. 2004. H2AX: the histone guardian of the genome. DNA Repair 3:959–967.
   PubMed Web of Science ®Google Scholar
• Gottesfeld, J. M., and D. J. Forbes. 1997. Mitotic repression of the transcriptional machinery. Trends Biochem. Sci. 22:197–202.
   PubMed Web of Science ®Google Scholar
• Gozani, O., J. G. Patton, and R. Reed. 1994. A novel set of spliceosome-associated proteins and the essential splicing factor PSF bind stably to pre-mRNA prior to catalytic step II of the splicing reaction. EMBO J. 13:3356–3367.
   PubMedGoogle Scholar
• Gozani, O., R. Feld, and R. Reed. 1996. Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A. Genes Dev. 15:233–243.
   Google Scholar
• He, J., S. Choe, R. Walker, P. Di Marzio, and D. O. Morgan, and N. R. Landau. 1995. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:6705–6711.
   PubMed Web of Science ®Google Scholar
• Igel, H., S. Wells, R. Perriman, and M. Ares, Jr. 1998. Conservation of structure and subunit interactions in yeast homologues of splicing factor 3b (SF3b) subunits. RNA 4:1–10.
   PubMedGoogle Scholar
• Jowett, J. B., V. Planelles, B. Poon, N. P. Shah, M. L. Chen, and I. S. Chen. 1995. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2+M phase of the cell cycle. J. Virol. 69:6304–6313.
   PubMed Web of Science ®Google Scholar
• Kittler, R., G. Putz, L. Pelletier, I. Poser, A. K. Heninger, D. Drechsel, S. Fischer, I. Konstantinova, B. Habermann, H. Grabner, M. L. Yaspo, H. Himmelbauer, B. Korn, K. Neugebauer, M. T. Pisabarro, and F. Buchholz. 2004. An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature 432:1036–1040.
   PubMed Web of Science ®Google Scholar
• Kramer, A. 1996. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65:367–409.
   PubMed Web of Science ®Google Scholar
• Kuramitsu, M., C. Hashizume, N. Yamamoto, A. Azuma, M. Kamata, N. Yamamoto, Y. Tanaka, and Y. Aida. 2005. A novel role for Vpr of human immunodeficiency virus type 1 as a regulator of the splicing of cellular pre-mRNA. Microbes Infect. 7:1150–1160.
   PubMedGoogle Scholar
• Lai, M., E. S. Zimmerman, V. Planelles, and J. Chen. 2005. Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo. J. Virol. 79:15443–15451.
   PubMedGoogle Scholar
• Li, X., J. Wang, and J. L. Manley. 2005. Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation. Genes Dev. 19:2705–2714.
   PubMed Web of Science ®Google Scholar
• Li, X., and J. L. Manley. 2005. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 122:365–378.
   PubMed Web of Science ®Google Scholar
• Macreadie, I. G., L. A. Castelli, D. R. Hewish, A. Kirkpatrick, A. C. Ward, and A. A. Azad. 1995. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc. Natl. Acad. Sci. USA 92:2770–2774.
   PubMed Web of Science ®Google Scholar
• Masuda, M., Y. Nagai, N. Oshima, K. Tanaka, H. Murakami, H. Igarashi, and H. Okayama. 2000. Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr. J. Virol. 74:2636–2646.
   PubMedGoogle Scholar
• Misteli, T., J. F. Caceres, and D. L. Spector. 1997. The dynamics of a pre-mRNA splicing factor in living cells. Nature 387:523–527.
   PubMed Web of Science ®Google Scholar
• Mueller, S. M., and S. M. Lang. 2002. The first HxRxG motif in simian immunodeficiency virus mac239 Vpr is crucial for G2/M cell cycle arrest. J. Virol. 76:11704–11709.
   PubMedGoogle Scholar
• Nurse, P. 1990. Universal control mechanism regulating onset of M-phase. Nature 344:503–508.
   PubMed Web of Science ®Google Scholar
• Pauling, M. H., D. S. McPheeters, and M. Ares, Jr. 2000. Functional Cus1p is found with Hsh155p in a multiprotein splicing factor associated with U2 snRNA. Mol. Cell. Biol. 20:2176–2185.
   PubMedGoogle Scholar
• Re, F., D. Braaten, E. K. Franke, and J. Luban. 1995. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69:6859–6864.
   PubMed Web of Science ®Google Scholar
• Reed, R. 1996. Initial splice-site recognition and pairing during pre-mRNA splicing. Curr. Opin. Genet. Dev. 6:215–220.
   PubMed Web of Science ®Google Scholar
• Rogakou, E. P., D. R. Pilch, A. H. Orr, V. S. Ivanova, and W. M. Bonner. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:5858–5868.
   PubMed Web of Science ®Google Scholar
• Rogakou, E. P., C. Boon, C. Redon, and W. M. Bonner. 1999. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146:905–916.
   PubMed Web of Science ®Google Scholar
• Rogel, M. E., L. I. Wu, and M. Emerman. 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 2:882–888.
   Google Scholar
• Roshal, M., B. Kim, Y. Zhu, P. Nghiem, and V. Planelles. 2003. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J. Biol. Chem. 278:25879–25886.
   PubMedGoogle Scholar
• Russell, C. S., S. Ben-Yehuda, I. Dix, M. Kupiec, and J. D. Beggs. 2000. Functional analyses of interacting factors involved in both pre-mRNA splicing and cell cycle progression in Saccharomyces cerevisiae. RNA 6:1565–1572.
   PubMedGoogle Scholar
• Sakai, K., J. Dimas, and M. J. Lenardo. 2006. The Vif and Vpr accessory proteins independently cause HIV-1-induced T-cell cytopathicity and cell cycle arrest. Proc. Natl. Acad. Sci. USA 109:3369–3374.
   Google Scholar
• Sherman, M. P., C. M. de Noronha, L. A. Eckstein, J. Hataye, P. Mundt, S. A. Williams, J. A. Neidleman, M. A. Goldsmith, and W. C. Greene. 2003. Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages. J. Virol. 77:7582–7589.
   PubMedGoogle Scholar
• Shin, C., and J. L. Manley. 2002. The SR protein SRp38 represses splicing in M phase cells. Cell 111:407–417.
   PubMed Web of Science ®Google Scholar
• Staknis, D., and R. Reed. 1994. Direct interactions between pre-mRNA and six U2 small nuclear ribonucleoproteins during spliceosome assembly. Mol. Cell. Biol. 14:2994–3005.
   PubMedGoogle Scholar
• Terada, Y., M. Tatsuka, S. Jinno, and H. Okayama. 1995. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376:358–362.
   PubMed Web of Science ®Google Scholar
• Terada, Y., M. Tatsuka, F. Suzuki, Y. Yasuda, S. Fujita, and M. Otsu. 1998. AIM-1: a mammalian midbody-associated protein required for cytokinesis. EMBO J. 17:667–676.
   PubMed Web of Science ®Google Scholar
• Terada, Y., Y. Uetake, and R. Kuriyama. 2003. Interaction of Aurora-A and centrosomin at the microtubule-nucleating site in Drosophila and mammalian cells. J. Cell Biol. 163:757–763.
   Google Scholar
• Terada, Y. 2006. Aurora-B/AIM-1 regulates dynamic behavior of HP1 alpha at G2-M transition. Mol. Biol. Cell 17:3232–3241.
   PubMedGoogle Scholar
• Ward, I., M. K. Minn, and J. Chen. 2004. UV-induced ataxia-telangiectasia-mutated and Rad3-related (ATR) activation requires replication stress. J. Biol. Chem. 279:9677–9680.
   PubMedGoogle Scholar
• Wells, S. E., M. Neville, M. Haynes, J. Wang, H. Igel, and M. Ares, Jr. 1996. CUS1, a suppressor of cold-sensitive U2 snRNA mutations, is a novel yeast splicing factor homologous to human SAP 145. Genes Dev. 10:220–232.
   PubMedGoogle Scholar
• Will, C., and R. Luhrman. 1997. Protein functions in pre-mRNA splicing. Curr. Opin. Cell Biol. 9:320–328.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., and R. T. Elder. 2000. HIV-1 VPR modulates cell cycle G2/M transition through an alternative cellular mechanism other than the classic mitotic checkpoints. Front. Biosci. 5:D905–916.
   PubMed Web of Science ®Google Scholar
• Zimmerman, E. S., J. Chen, J. L. Andersen, O. Ardon, J. L. Dehart, J. Blackett, S. K. Choudhary, D. Camerini, P. Nghiem, and V. Planelles. 2004. Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation. Mol. Cell. Biol. 24:9286–9894.
   PubMed Web of Science ®Google Scholar
• Zou, L., D. Cortez, and S. J. Elledge. 2002. Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin. Genes Dev. 16:198–208.
   PubMed Web of Science ®Google Scholar